Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Visningar
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Visa mer
Facebook-kommentarer
Inga kommentarer hittades